HEADER HYDROLASE 06-MAR-05 1Z1R
TITLE HIV-1 PROTEASE COMPLEXED WITH MACROCYCLIC PEPTIDOMIMETIC INHIBITOR 2
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: POL POLYPROTEIN;
COMPND 3 CHAIN: A, B;
COMPND 4 FRAGMENT: HIV-1 PROTEASE;
COMPND 5 EC: 3.4.23.16;
COMPND 6 ENGINEERED: YES;
COMPND 7 MUTATION: YES
SOURCE MOL_ID: 1;
SOURCE 2 SYNTHETIC: YES;
SOURCE 3 OTHER_DETAILS: CHEMICALLY SYNTHESISED BY SOLID PHASE PEPTIDE
SOURCE 4 SYNTHESIS
KEYWDS MACROCYCLIC INHIBITORS, PEPTIDOMIMETIC INHIBITORS, HIV1 PROTEASE,
KEYWDS 2 HYDROLASE
EXPDTA X-RAY DIFFRACTION
AUTHOR J.L.MARTIN,J.BEGUN,A.SCHINDELER,W.A.WICKRAMASINGHE,D.ALEWOOD,
AUTHOR 2 P.F.ALEWOOD,D.A.BERGMAN,R.I.BRINKWORTH,G.ABBENANTE,D.R.MARCH,
AUTHOR 3 R.C.REID,D.P.FAIRLIE
REVDAT 5 15-NOV-23 1Z1R 1 REMARK
REVDAT 4 25-OCT-23 1Z1R 1 REMARK
REVDAT 3 10-NOV-21 1Z1R 1 REMARK SEQADV HETSYN LINK
REVDAT 2 24-FEB-09 1Z1R 1 VERSN
REVDAT 1 22-MAR-05 1Z1R 0
SPRSDE 22-MAR-05 1Z1R 1B6O
JRNL AUTH J.L.MARTIN,J.BEGUN,A.SCHINDELER,W.A.WICKRAMASINGHE,
JRNL AUTH 2 D.ALEWOOD,P.F.ALEWOOD,D.A.BERGMAN,R.I.BRINKWORTH,
JRNL AUTH 3 G.ABBENANTE,D.R.MARCH,R.C.REID,D.P.FAIRLIE
JRNL TITL MOLECULAR RECOGNITION OF MACROCYCLIC PEPTIDOMIMETIC
JRNL TITL 2 INHIBITORS BY HIV-1 PROTEASE
JRNL REF BIOCHEMISTRY V. 38 7978 1999
JRNL REFN ISSN 0006-2960
JRNL PMID 10387041
JRNL DOI 10.1021/BI990174X
REMARK 2
REMARK 2 RESOLUTION. 1.85 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : X-PLOR 3.851
REMARK 3 AUTHORS : BRUNGER
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.85
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 8.00
REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000
REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL
REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL
REMARK 3 COMPLETENESS (WORKING+TEST) (%) : NULL
REMARK 3 NUMBER OF REFLECTIONS : 14672
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT
REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM
REMARK 3 R VALUE (WORKING SET) : 0.176
REMARK 3 FREE R VALUE : 0.209
REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL
REMARK 3 FREE R VALUE TEST SET COUNT : 1494
REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL
REMARK 3
REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN.
REMARK 3 TOTAL NUMBER OF BINS USED : NULL
REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.85
REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.92
REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL
REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL
REMARK 3 BIN R VALUE (WORKING SET) : 0.2904
REMARK 3 BIN FREE R VALUE : 0.3059
REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL
REMARK 3 BIN FREE R VALUE TEST SET COUNT : 120
REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL
REMARK 3
REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.
REMARK 3 PROTEIN ATOMS : 1490
REMARK 3 NUCLEIC ACID ATOMS : 0
REMARK 3 HETEROGEN ATOMS : 56
REMARK 3 SOLVENT ATOMS : 102
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : NULL
REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : -1.91100
REMARK 3 B22 (A**2) : -0.07200
REMARK 3 B33 (A**2) : 1.98200
REMARK 3 B12 (A**2) : 0.00000
REMARK 3 B13 (A**2) : 0.00000
REMARK 3 B23 (A**2) : 0.00000
REMARK 3
REMARK 3 ESTIMATED COORDINATE ERROR.
REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL
REMARK 3 ESD FROM SIGMAA (A) : NULL
REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL
REMARK 3
REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR.
REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL
REMARK 3 ESD FROM C-V SIGMAA (A) : NULL
REMARK 3
REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES.
REMARK 3 BOND LENGTHS (A) : 0.009
REMARK 3 BOND ANGLES (DEGREES) : 1.620
REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL
REMARK 3 IMPROPER ANGLES (DEGREES) : NULL
REMARK 3
REMARK 3 ISOTROPIC THERMAL MODEL : ANISOTROPIC, WITH BULK SOLVENT
REMARK 3 CORRECTION
REMARK 3
REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA
REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL
REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL
REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL
REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL
REMARK 3
REMARK 3 NCS MODEL : NULL
REMARK 3
REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT
REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL
REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL
REMARK 3
REMARK 3 PARAMETER FILE 1 : NULL
REMARK 3 TOPOLOGY FILE 1 : NULL
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4
REMARK 4 1Z1R COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 11-MAR-05.
REMARK 100 THE DEPOSITION ID IS D_1000032188.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 01-JAN-96
REMARK 200 TEMPERATURE (KELVIN) : 289
REMARK 200 PH : 5.5
REMARK 200 NUMBER OF CRYSTALS USED : 1
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : N
REMARK 200 RADIATION SOURCE : ROTATING ANODE
REMARK 200 BEAMLINE : NULL
REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RU200
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418
REMARK 200 MONOCHROMATOR : NI FILTER
REMARK 200 OPTICS : YALE MIRRORS
REMARK 200
REMARK 200 DETECTOR TYPE : IMAGE PLATE
REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IIC
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO
REMARK 200 DATA SCALING SOFTWARE : SCALEPACK
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 14904
REMARK 200 RESOLUTION RANGE HIGH (A) : 1.850
REMARK 200 RESOLUTION RANGE LOW (A) : 50.000
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 89.8
REMARK 200 DATA REDUNDANCY : 2.400
REMARK 200 R MERGE (I) : NULL
REMARK 200 R SYM (I) : 0.07300
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 9.8000
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.85
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.92
REMARK 200 COMPLETENESS FOR SHELL (%) : 76.5
REMARK 200 DATA REDUNDANCY IN SHELL : NULL
REMARK 200 R MERGE FOR SHELL (I) : NULL
REMARK 200 R SYM FOR SHELL (I) : 0.29500
REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.200
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS
REMARK 200 SOFTWARE USED: X-PLOR
REMARK 200 STARTING MODEL: 1B6O
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 37.00
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.96
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: 30-60% AMMONIUM SULFATE, 0.1M ACETATE
REMARK 280 BUFFER, PH 5.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -X+1/2,-Y,Z+1/2
REMARK 290 3555 -X,Y+1/2,-Z+1/2
REMARK 290 4555 X+1/2,-Y+1/2,-Z
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 25.60000
REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000
REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 30.95000
REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 29.50000
REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 30.95000
REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 25.60000
REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 29.50000
REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 300 REMARK: THE BIOLOGICAL UNIT IS A HOMODIMER. THE TWO MOLECULES IN
REMARK 300 THE ASYMMETRIC UNIT REPRESENT THE BIOLOGICAL ASSEMBLY
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 TOTAL BURIED SURFACE AREA: 5360 ANGSTROM**2
REMARK 350 SURFACE AREA OF THE COMPLEX: 9180 ANGSTROM**2
REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -64.0 KCAL/MOL
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 470
REMARK 470 MISSING ATOM
REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER;
REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER;
REMARK 470 I=INSERTION CODE):
REMARK 470 M RES CSSEQI ATOMS
REMARK 470 LYS A 7 CG CD CE NZ
REMARK 470 LYS A 41 CG CD CE NZ
REMARK 470 LYS A 43 CG CD CE NZ
REMARK 470 LYS A 45 CG CD CE NZ
REMARK 470 LYS B 141 CG CD CE NZ
REMARK 470 LYS B 143 CG CD CE NZ
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 GLU B 135 115.71 -38.75
REMARK 500
REMARK 500 REMARK: NULL
REMARK 800
REMARK 800 SITE
REMARK 800 SITE_IDENTIFIER: AC1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 501
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC2
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 502
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC3
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 503
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC4
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE HBH A 201
REMARK 900
REMARK 900 RELATED ENTRIES
REMARK 900 RELATED ID: 1B6N RELATED DB: PDB
REMARK 900 RELATED ID: 1B6J RELATED DB: PDB
REMARK 900 RELATED ID: 1B6O RELATED DB: PDB
REMARK 900 RELATED ID: 1B6L RELATED DB: PDB
REMARK 900 RELATED ID: 1B6K RELATED DB: PDB
REMARK 900 RELATED ID: 1B6M RELATED DB: PDB
REMARK 900 RELATED ID: 1B6P RELATED DB: PDB
DBREF 1Z1R A 1 99 UNP P03369 POL_HV1A2 57 155
DBREF 1Z1R B 101 199 UNP P03369 POL_HV1A2 57 155
SEQADV 1Z1R LYS A 7 UNP P03369 GLN 63 ENGINEERED MUTATION
SEQADV 1Z1R ILE A 33 UNP P03369 LEU 89 ENGINEERED MUTATION
SEQADV 1Z1R ABA A 67 UNP P03369 CYS 123 ENGINEERED MUTATION
SEQADV 1Z1R ABA A 95 UNP P03369 CYS 151 ENGINEERED MUTATION
SEQADV 1Z1R LYS B 107 UNP P03369 GLN 63 ENGINEERED MUTATION
SEQADV 1Z1R ILE B 133 UNP P03369 LEU 89 ENGINEERED MUTATION
SEQADV 1Z1R ABA B 167 UNP P03369 CYS 123 ENGINEERED MUTATION
SEQADV 1Z1R ABA B 195 UNP P03369 CYS 151 ENGINEERED MUTATION
SEQRES 1 A 99 PRO GLN ILE THR LEU TRP LYS ARG PRO LEU VAL THR ILE
SEQRES 2 A 99 ARG ILE GLY GLY GLN LEU LYS GLU ALA LEU LEU ASP THR
SEQRES 3 A 99 GLY ALA ASP ASP THR VAL ILE GLU GLU MET ASN LEU PRO
SEQRES 4 A 99 GLY LYS TRP LYS PRO LYS MET ILE GLY GLY ILE GLY GLY
SEQRES 5 A 99 PHE ILE LYS VAL ARG GLN TYR ASP GLN ILE PRO VAL GLU
SEQRES 6 A 99 ILE ABA GLY HIS LYS ALA ILE GLY THR VAL LEU VAL GLY
SEQRES 7 A 99 PRO THR PRO VAL ASN ILE ILE GLY ARG ASN LEU LEU THR
SEQRES 8 A 99 GLN ILE GLY ABA THR LEU ASN PHE
SEQRES 1 B 99 PRO GLN ILE THR LEU TRP LYS ARG PRO LEU VAL THR ILE
SEQRES 2 B 99 ARG ILE GLY GLY GLN LEU LYS GLU ALA LEU LEU ASP THR
SEQRES 3 B 99 GLY ALA ASP ASP THR VAL ILE GLU GLU MET ASN LEU PRO
SEQRES 4 B 99 GLY LYS TRP LYS PRO LYS MET ILE GLY GLY ILE GLY GLY
SEQRES 5 B 99 PHE ILE LYS VAL ARG GLN TYR ASP GLN ILE PRO VAL GLU
SEQRES 6 B 99 ILE ABA GLY HIS LYS ALA ILE GLY THR VAL LEU VAL GLY
SEQRES 7 B 99 PRO THR PRO VAL ASN ILE ILE GLY ARG ASN LEU LEU THR
SEQRES 8 B 99 GLN ILE GLY ABA THR LEU ASN PHE
MODRES 1Z1R ABA A 67 ALA ALPHA-AMINOBUTYRIC ACID
MODRES 1Z1R ABA A 95 ALA ALPHA-AMINOBUTYRIC ACID
MODRES 1Z1R ABA B 167 ALA ALPHA-AMINOBUTYRIC ACID
MODRES 1Z1R ABA B 195 ALA ALPHA-AMINOBUTYRIC ACID
HET ABA A 67 6
HET ABA A 95 6
HET ABA B 167 6
HET ABA B 195 6
HET SO4 A 502 5
HET SO4 A 503 5
HET HBH A 201 46
HET SO4 B 501 5
HETNAM ABA ALPHA-AMINOBUTYRIC ACID
HETNAM SO4 SULFATE ION
HETNAM HBH 2-[(8S,11S)-11-{(1R)-1-HYDROXY-2-
HETNAM 2 HBH [ISOPENTYL(PHENYLSULFONYL)AMINO]ETHYL}-6,9-DIOXO-2-
HETNAM 3 HBH OXA-7,10-DIAZABICYCLO[11.2.2]HEPTADECA-1(15),13,16-
HETNAM 4 HBH TRIEN-8-YL]ACETAMIDE
HETSYN HBH 2-(11-{2-[BENZENESULFONYL-(3-METHYL-BUTYL)-AMINO]-1-
HETSYN 2 HBH HYDROXY-ETHYL}-6,9-DIOXO-2-OXA-7,10-DIAZA-
HETSYN 3 HBH BICYCLO[11.2.2]HEPTADECA-1(16),13(17),14-TRIEN-8-YL)-
HETSYN 4 HBH ACETAMIDE; INHIBITOR 2
FORMUL 1 ABA 4(C4 H9 N O2)
FORMUL 3 SO4 3(O4 S 2-)
FORMUL 5 HBH C29 H40 N4 O7 S
FORMUL 7 HOH *102(H2 O)
HELIX 1 1 GLY A 86 THR A 91 1 6
HELIX 2 2 GLY B 186 THR B 191 1 6
HELIX 3 3 GLN B 192 GLY B 194 5 3
SHEET 1 A 4 GLN A 2 THR A 4 0
SHEET 2 A 4 THR B 196 ASN B 198 -1 O LEU B 197 N ILE A 3
SHEET 3 A 4 THR A 96 ASN A 98 -1 N ASN A 98 O THR B 196
SHEET 4 A 4 GLN B 102 THR B 104 -1 O ILE B 103 N LEU A 97
SHEET 1 B 8 LYS A 43 GLY A 48 0
SHEET 2 B 8 PHE A 53 ILE A 66 -1 O VAL A 56 N LYS A 45
SHEET 3 B 8 HIS A 69 VAL A 77 -1 O HIS A 69 N ILE A 66
SHEET 4 B 8 VAL A 32 ILE A 33 1 N ILE A 33 O LEU A 76
SHEET 5 B 8 ILE A 84 ILE A 85 -1 O ILE A 84 N VAL A 32
SHEET 6 B 8 GLN A 18 LEU A 24 1 N LEU A 23 O ILE A 85
SHEET 7 B 8 LEU A 10 ILE A 15 -1 N ILE A 13 O LYS A 20
SHEET 8 B 8 PHE A 53 ILE A 66 -1 O GLU A 65 N ARG A 14
SHEET 1 C 8 LYS B 143 GLY B 149 0
SHEET 2 C 8 GLY B 152 ILE B 166 -1 O GLN B 158 N LYS B 143
SHEET 3 C 8 HIS B 169 GLY B 178 -1 O HIS B 169 N ILE B 166
SHEET 4 C 8 VAL B 132 GLU B 134 1 N ILE B 133 O LEU B 176
SHEET 5 C 8 ILE B 184 ILE B 185 -1 O ILE B 184 N VAL B 132
SHEET 6 C 8 GLN B 118 LEU B 124 1 N LEU B 123 O ILE B 185
SHEET 7 C 8 LEU B 110 ILE B 115 -1 N ILE B 115 O GLN B 118
SHEET 8 C 8 GLY B 152 ILE B 166 -1 O GLU B 165 N ARG B 114
LINK C ILE A 66 N ABA A 67 1555 1555 1.33
LINK C ABA A 67 N GLY A 68 1555 1555 1.32
LINK C GLY A 94 N ABA A 95 1555 1555 1.33
LINK C ABA A 95 N THR A 96 1555 1555 1.34
LINK C ILE B 166 N ABA B 167 1555 1555 1.33
LINK C ABA B 167 N GLY B 168 1555 1555 1.33
LINK C GLY B 194 N ABA B 195 1555 1555 1.34
LINK C ABA B 195 N THR B 196 1555 1555 1.33
SITE 1 AC1 6 GLY A 68 HIS A 69 LYS A 70 HOH A 373
SITE 2 AC1 6 PRO B 101 LYS B 155
SITE 1 AC2 2 PRO A 1 HIS A 69
SITE 1 AC3 7 ARG A 14 GLY A 17 HOH A 390 ILE B 115
SITE 2 AC3 7 GLY B 116 GLY B 117 HOH B 314
SITE 1 AC4 20 ASP A 25 GLY A 27 ALA A 28 ASP A 29
SITE 2 AC4 20 ASP A 30 GLY A 48 GLY A 49 ILE A 50
SITE 3 AC4 20 VAL A 82 HOH A 301 HOH A 341 ARG B 108
SITE 4 AC4 20 ASP B 125 GLY B 127 ALA B 128 ASP B 130
SITE 5 AC4 20 GLY B 148 GLY B 149 VAL B 182 ILE B 184
CRYST1 51.200 59.000 61.900 90.00 90.00 90.00 P 21 21 21 8
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.019531 0.000000 0.000000 0.00000
SCALE2 0.000000 0.016949 0.000000 0.00000
SCALE3 0.000000 0.000000 0.016155 0.00000